We built Zipline—the world’s first and only national scale on-demand UAS delivery service—to solve that problem. Joining the fight against a global pandemic, Zipline transported hundreds of thousands of COVID-19 vaccines, test samples, and personal protective equipment (PPE) in Ghana, Rwanda, and the United States. So far, Zipline has flown tens of millions of miles and completed over 270,000 commercial deliveries worldwide.  

Zipline's pharmacists-led success represents a much-needed paradigm shift on how we integrate advanced technology into pharmacy practice and health systems more broadly.

Dr Joanna C Moullin, pharmacy practice lecturer and a leader in implementation science from Curtin University, WA, Australia.
 
Dr Moullin completed a PhD between Australia (University of Technology Sydney) and Spain (University of Granada) applying and advancing the field of implementation science in community pharmacy. She subsequently completed a postdoctoral fellowship at the University of California, San Diego. Dr Moullin’s work includes collating the core components of implementation as a Generic Implementation Framework (GIF) and contextualised them for community pharmacy as the Framework for the Implementation of Services in Pharmacy (FISpH). She has also developed a model for the evaluation of hybrid design studies and tools to measure implementation. In 2017, she was awarded the Society for Implementation Research Collaboration (SIRC) Outstanding New Investigator Award. A pharmacist by profession, she now focuses on implementation across a range of diverse clinical and community settings. 

Plenary: Harnessing implementation science to walk the talk

Implementation science has been embraced by funders, policymakers, and researchers alike, but is it really a silver bullet?  This presentation will begin with a historical overview of implementation science and its application in social pharmacy. Dr Moullin will share examples of projects, her experiences with implementation, and directions for future work. 

Dr Faye McMillan, Associate Professor in Aboriginal and Torres Strait Islander Health, School of Population Health, University of New South Wales,  Australia.  

Associate Professor Dr Faye McMillan AM is a Wiradjuri yinaa (woman) originally from Trangie, NSW. Faye is a community pharmacist and is recognised as the first Indigenous Australian to hold a western degree in pharmacy in this country. Faye is a strong advocate for improving Indigenous health care across professions, notably being a founding member and President of Indigenous Allied Health Australia. Faye is currently one of two Deputy National Rural Health Commissioners and works at UNSW as the Associate Professor in Aboriginal and Torres Strait Islander Health in the School of Population Health, as well as a board member of The Australian Pharmacy Council (APC) and is also the chair of the APC Indigenous health strategy group.Faye has received numerous accolades for her leadership and contribution to population health, education, equity, and the community. In 2021 Professor McMillan was appointed as a Member (AM) of the Order of Australia in the Queen’s Birthday 2021 Honours List. Professor McMillan’s appointment recognises her significant service to Indigenous mental health, and to tertiary education.

Plenary: Coming of age

2022 marks 21 years since the first Aboriginal person became a registered pharmacist in Australia. 21 years, coming of age, what does it mean for the current pharmacy profession and what is the impact on the future pharmacy workforce. Using my own lived experiences of ‘othering’ to bring you on the journey of where we have been, where we are now and where we want to be in the future in building global capacity in a time of change.

Professor Jon C Schommer, University of Minnesota, United States  

Jon C. Schommer, R.Ph., Ph.D., is a professor at the University of Minnesota. He received his BS, MS, and PhD degrees from the University of Wisconsin – Madison. Since graduating with his PhD in 1992, he has devoted his career to teaching and research. 
His research is focused upon information processing and decision making related to the provision, use, and evaluation of drug products and pharmacist services. He recently completed the National Consumer Survey on the Medication Experience -- a study of over 38,000 individuals. 
Dr. Schommer has served as Peters Chair for Pharmacy Practice Innovation, President for the Academy of Pharmaceutical Research and Science, and Trustee for the American Pharmacists Association. He holds a Distinguished Teaching Professor appointment and was inducted into the Academy of Distinguished Teachers at the University of Minnesota. In March 2019, he received a Lifetime Research Achievement Award from the Academy of Pharmaceutical Research and Science. In July 2021, he received the American Association of Colleges of Pharmacy - Graduate Education Achievement Award.

Plenary: The first 100 year of social pharmacy: We're half-way there 

This plenary presentation will outline the development of Social Pharmacy from 1970 to 2022 and show how this discipline is highly respected, productive and an integral part of translational research in pharmacy that spans (1) basic science research, (2) translation to humans, (3) translation to patients, (4) translation to practice, and (5) translation to communities. The integrated nature of research in pharmacy that spans from bench to bedside - to best practice -to best outcome - to best value, opens new opportunity for the Social Pharmacy discipline to further develop as an integrated and multi-faceted scientific domain. 

Over the past 50 years this discipline has positioned itself through an intentional outward focus that met individual, societal and professional needs. The focus was on the “other” instead of the “us.” It also created organization and structure by articulating a clear polity, developing places to meet, a healthy system of groups, defined leadership, processes and procedures. Members are being integrated into this healthy discipline on a continual basis.

Social Pharmacy has reached a point where it is highly respected and productive. It would be tempting to become complacent and turn the previous stages of development into ends instead of means. Members could be tempted to hold onto the programs, processes, and styles where they are comfortable. It is proposed that now is a good time for our discipline to invest in rebirth through a renewed commitment to an intentional outward focus. Rebirth does not give up the strong foundations that are already in place. By rebirth, we mean that we are poised to take an intentional outward focus and discover what new opportunities lay before us. What does this look like? How are you contributing to such an outward focus? What are the next, great opportunities for us? During this session, audience members will be invited to tell their stories and share their ideas.

Professor Claire Anderson, University of Nottingham, United Kingdom

Claire Anderson is Chair of Social Pharmacy, Division of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham, UK. She is President of the Royal Pharmaceutical Society. As a leading social pharmacy academic her work focuses on designing and evaluating educational, pharmacy practice and health service models and exploring patient's experiences of using medicines. Her research seeks to improve patient and public health in the light of contemporary health care reforms. She has published over 150 refereed papers, one book, ten book chapters and numerous conference abstracts. She is a trustee of the Commonwealth Pharmacists Association. She is a past president of the Academic Section of the International Pharmaceutical Federation (FIP).

Plenary: A global vision for social pharmacy: building capacity in a time of change through integration, impact and influence

The development of social pharmacy as a discipline has been internationally diverse and it has been defined in many ways. I will begin by addressing the question “What is social pharmacy?” by considering the environment in which it has developed and what we can learn for the future. I will then consider how we develop the field under a number of themes including working with others, patient and public involvement, impact and influence. I will then examine the future of social pharmacy and discuss the importance  research and academic capacity building, Finally, I will  provide some thoughts on how social pharmacy might continue to develop given the global challenges we face including; pandemics, climate change ,security, migration, global inequalities in access to medicines, workforce issues, shifting modes of delivery of healthcare, increasing use of technology, AI and the various agendas for medicines’ design and development.